Antiangiogenic therapies in gastric cancer: trusting the pathway

Ann Oncol. 2016 Dec;27(12):2141-2143. doi: 10.1093/annonc/mdw541. Epub 2016 Oct 13.

Authors

M Alsina¹, C Hierro², J Tabernero²

Affiliations

¹ Department of Medical Oncology, Vall d'Hebron Institute of Oncology (V.H.I.O.), Vall d'Hebron University Hospital, Barcelona, Spain malsina@vhio.net.
² Department of Medical Oncology, Vall d'Hebron Institute of Oncology (V.H.I.O.), Vall d'Hebron University Hospital, Barcelona, Spain.

PMID: 27742655
DOI: 10.1093/annonc/mdw541

No abstract available

Publication types

Editorial
Comment

MeSH terms

Angiogenesis Inhibitors*
Humans
Neovascularization, Pathologic
Stomach Neoplasms*

Substances

Angiogenesis Inhibitors